跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,334 条关于
“JNJ-77242114”
全部
1,334
临床试验
808
药物
427
机构
5
资讯
94
去年
Novel Oral Psoriasis Therapies Show Promise: TYK2 Inhibitors Lead Breakthrough Advances
去年
JNJ-2113 Shows Promising Phase 3 Results for Plaque Psoriasis
去年
Oral JNJ-2113 Demonstrates Efficacy in Phase 3 Trials for Moderate-to-Severe Psoriasis
去年
J&J Advances Novel Liposomal Vaccine JNJ-2056 for Alzheimer's and Tauopathies
去年
Nanobiotix Secures EU Regulatory Harmonization and New Patent for Cancer Radioenhancer JNJ-1900
去年
Nanobiotix's JNJ-1900 Shows Promising Results in Anti-PD-1 Resistant Melanoma Patients
去年
JNJ-1900 Shows Promise in Phase 1 Trial for Advanced Pancreatic Cancer
去年
JNJ-2113 Demonstrates Significant Skin Clearance in Phase 3 Psoriasis Trials
8个月前
Johnson & Johnson Discontinues Mid-Stage Eczema Trial After JNJ-5939 Fails to Meet Efficacy Goals
8个月前
Johnson & Johnson Terminates Phase 2b DUPLEX-AD Study of JNJ-95475939 Following Interim Efficacy Analysis
第 1 页,共 10 页
上一页
下一页